Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Tech Monitor.
Press releases published on April 23, 2025
TASSHUB Debuts Market for Creators on Solana, it's 484% up in just 24 Hours After Launch
GlobeNewswire
·
April 23, 2025
HARNDUP, Denmark, April 23, 2025 (GLOBE NEWSWIRE) -- Creator-based Web 3 platform TASSHUB token officially launched on Solana Thursday, with the promise of bridging decentralization to the adult entertainment industry. Now visible on market aggregator …
Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025
GlobeNewswire
·
April 23, 2025
Five abstracts accepted for poster presentations WARMINSTER, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today …
TomTom provides enhanced navigation to smart’s in-vehicle solutions
GlobeNewswire
·
April 23, 2025
SHANGHAI, April 23, 2025 (GLOBE NEWSWIRE) -- Auto Shanghai – TomTom (TOM2), the location technology specialist, today announced that it has been selected by smart, the premium all-electric intelligent auto brand, to provide enhanced full-stack navigation …
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies
GlobeNewswire
·
April 23, 2025
VERAXA’s Novel BiTAC Platform has the Potential to Deliver Multiple Next-Generation Solid Tumor Cancer Therapies, Including Novel Antibody-Drug Conjugate ("ADC") and Bispecific T-cell Engager ("TCE") Candidates, with Strong and Differentiated Clinical …
Notes-App.AI Launches Smarter Notes AI Platform for Everyday Creativity
GlobeNewswire
·
April 23, 2025
New York, April 23, 2025 (GLOBE NEWSWIRE) -- Today, Notes-App.AI officially launched its groundbreaking Notes AI platform, transforming the process of how humans take, manage, and interact with their individual ideas. A next-generation notes app, Notes-App …
浩鼎将在AACR发表七篇海报论文
GlobeNewswire
·
April 23, 2025
台北讯, April 23, 2025 (GLOBE NEWSWIRE) -- 浩鼎生技（TPEx: 4174.TWO）今日首次公布其自主开发的次世代GlycOBI®技术平台所开发抗体药物偶联体（ADC）OBI-902的非临床数据，显示其具备优异的药物动力学特性，并在多种具挑战性的实体肿瘤动物模型中展现持续的抗肿瘤活性，且优于目前已上市的TROP2 ADC，显示OBI-902具备成为同类最佳ADC的潜力。OBI-992则为采用半胱氨酸连接技术的TROP2靶向ADC，其耐药性特征异于现有同类产品。 在本次 …
浩鼎將在AACR發表七篇海報論文
GlobeNewswire
·
April 23, 2025
台北電, April 23, 2025 (GLOBE NEWSWIRE) -- 台灣浩鼎生技（TPEx: 4174. TWO）今首度公布其自主開發的次世代 GlycOBI® 技術平台所開發抗體藥物複合體（ADC）OBI-902 非臨床數據，具有優異的藥物動力學特性，以及在多種具挑戰性的實體腫瘤動物模型中展現持續的抗腫瘤活性，亦證明優於目前已上市的 TROP2 ADC，證明OBI-902 具有成為同類最佳ADC的潛力。OBI-992 為半胱胺酸連接技術的 TROP2 靶向 ADC，其耐藥性特徵有異於目前同類的 …
OBI Pharma Announces Poster Presentations at the AACR 2025 Annual Meeting for OBI-992 and OBI-902 Antibody-Drug Conjugates (ADCs), GlycOBI® and ThiOBI® ADC enabling technologies, the OBI-3424 prodrug, and Globo H (GH) science
GlobeNewswire
·
April 23, 2025
TAIPEI, Taiwan, April 23, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174. TWO) today announced nonclinical data for OBI-902, a potential best-in-class anti-TROP2 ADC developed using the next generation proprietary GlycOBI® technologies. OBI-902 …
Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025
GlobeNewswire
·
April 23, 2025
Salt Lake City, UT, April 22, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, will present preliminary data during the 2025 Digestive Disease Week (DDW) meeting from …